Answers are grounded in this paper and cite their sources.
Demonstrates potent BACE-1 inhibition in vitro, suggesting potential for Alzheimer's treatment.
Highly potent BACE-1 protease inhibitors have been developed from an inhibitors containing a hydroxyethylene (HE) core displaying aryloxymethyl or benzyloxymethyl P1 side chain and a methoxy P1' side chain. The target molecules were synthesized in good overall yields from chiral carbohydrate starting materials. The inhibitors show high BACE-1 potency and good selectivity against cathepsin D, where the most potent inhibitor furnishes BACE-1 K(i) << 1 nM and displays >1000-fold selectivity over cathepsin D.
No takes yet. Share an insight, caveat, or question.
Björklund et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: